» Authors » Kavitha Ramaswamy

Kavitha Ramaswamy

Explore the profile of Kavitha Ramaswamy including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 17
Citations 366
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Steinherz P, Mauguen A, Suser S, Ramaswamy K, Kobos R, Forlenza C, et al.
J Pediatr Hematol Oncol . 2025 Feb; 47(2):59-66. PMID: 39899689
We described the Memorial Sloan Kettering Cancer Center New York IIB (MSK-NYII) protocol pilot in 1993, for the treatment of acute lymphoblastic leukemia (ALL) in children at high risk of...
2.
Ramaswamy K, Rashid M, Ramasamy S, Jayavelu T, Venkataraman S
Viruses . 2022 Oct; 14(10). PMID: 36298755
RNA-dependent RNA polymerases (RdRPs) represent a distinctive yet versatile class of nucleic acid polymerases encoded by RNA viruses for the replication and transcription of their genome. The structure of the...
3.
Martin K, Deleveaux S, Cunningham M, Ramaswamy K, Thomas B, Lerma E, et al.
Dis Mon . 2022 Aug; 68(12):101465. PMID: 36008166
Pulmonary renal syndrome (PRS) is a constellation of different disorders that cause both rapidly progressive glomerulonephritis and diffuse alveolar hemorrhage. While antineutrophil cytoplasmic antibody associated vasculitis and anti-glomerular basement membrane...
4.
Ramaswamy K, Madariaga H, Zheng L, Thomas B, Lerma E
Dis Mon . 2022 Feb; 68(12):101330. PMID: 35221018
No abstract available.
5.
Ramaswamy K, Steinherz P, Agrawal A, Forlenza C, Mauguen A, Roshal M, et al.
Blood Adv . 2022 Jan; 6(8):2688-2694. PMID: 35008101
Effective reinduction regimens are needed for children with relapsed and refractory acute myeloid leukemia (AML), as outcomes remain poor. Therapeutic options are limited in this heavily pretreated patient population, many...
6.
Shahid S, Ramaswamy K, Flynn J, Mauguen A, Perica K, Park J, et al.
Transplant Cell Ther . 2021 Dec; 28(2):72.e1-72.e8. PMID: 34852305
Chimeric antigen receptor (CAR) T cells achieve response and durable remission in patients with relapsed/refractory (R/R) B cell malignancies. Following collection of patient T cells, chemotherapy ("bridging chemotherapy") is utilized...
7.
Martos-Rus C, Katz-Greenberg G, Lin Z, Serrano E, Whitaker-Menezes D, Domingo-Vidal M, et al.
Sci Rep . 2021 Feb; 11(1):2974. PMID: 33536542
In obesity, adipose tissue derived inflammation is associated with unfavorable metabolic consequences. Uremic inflammation is prevalent and contributes to detrimental outcomes. However, the contribution of adipose tissue inflammation in uremia...
8.
Ramaswamy K, Brahmbhatt Y, Xia J, Song Y, Zhang J
Hemodial Int . 2020 Mar; 24(3):406-413. PMID: 32141198
Introduction: Large interdialytic weight gain (IDWG) is associated with increased morbidity and mortality in chronic hemodialysis patients. Over 50% of patients at our inner city tertiary academic center dialysis unit...
9.
Ramaswamy K, Madariaga H, Thomas B, Lerma E
Dis Mon . 2019 Aug; :100869. PMID: 31420084
Advancement in kidney transplantation has led to prolonged survival in our population with kidney disease. Newer agents of immunosuppression have made this possible with less rejections and lesser opportunistic infections...
10.
Forlenza C, Zhang Y, Yao J, Benayed R, Steinherz P, Ramaswamy K, et al.
Cold Spring Harb Mol Case Stud . 2018 Nov; 4(6). PMID: 30455225
Acute megakaryoblastic leukemia (AMKL) constitutes ∼5%-15% of cases of non-Down syndrome AML in children, and in the majority of cases, chimeric oncogenes resulting from recurrent gene rearrangements are identified. Based...